| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATHA (ATHA) has 6 insiders with recent SEC Form 4 filings, including 5 buys and 1 sell. ATHA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 329.8K | $2.09M | - | |
| CEO | 40.8K | $280.9K | - | |
| Other | 20.7K | $142.3K | - | |
| Other | 14.0K | $96.2K | - | |
| CFO | 12.9K | $88.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | Church Kevin | Executive VP, Research | Sell | 2,614 | $2.69 | $7,031.66 | -4.3% | |
| Mar 31, 2022 | Romano Kelly A | Director | Buy | 8,000 | $13.11 | $104,880.00 | +2,540% | |
| Jan 25, 2021 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 311,111 | $22.50 | $6,999,997.50 | +10.0% | |
| Sep 22, 2020 | Edelman Joseph | Director, 10% Owner | Buy | 1,058,824 | $17.00 | $18,000,008.00 | +51.5% | |
| Sep 22, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,058,824 | $17.00 | $18,000,008.00 | +51.5% | |
| Sep 18, 2020 | Rtw Investments, LP63 | 10% Owner | Buy | 750,000 | $17.00 | $12,750,000.00 | +39.1% |